CN101791377B - 一种用于宫颈炎、宫颈肥大术后康复的中药制剂 - Google Patents
一种用于宫颈炎、宫颈肥大术后康复的中药制剂 Download PDFInfo
- Publication number
- CN101791377B CN101791377B CN2010101440513A CN201010144051A CN101791377B CN 101791377 B CN101791377 B CN 101791377B CN 2010101440513 A CN2010101440513 A CN 2010101440513A CN 201010144051 A CN201010144051 A CN 201010144051A CN 101791377 B CN101791377 B CN 101791377B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- herba
- chinese medicine
- Prior art date
Links
- 239000003814 drugs Substances 0.000 title claims abstract description 44
- 238000002360 preparation methods Methods 0.000 title claims abstract description 24
- 206010008323 Cervicitis Diseases 0.000 title claims abstract description 13
- 206010020880 Hypertrophy Diseases 0.000 title claims abstract description 12
- 208000006374 Uterine Cervicitis Diseases 0.000 title claims abstract description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 13
- 235000005035 ginseng Nutrition 0.000 claims abstract description 13
- 239000004863 Frankincense Substances 0.000 claims abstract description 10
- 240000003301 Agrimonia eupatoria Species 0.000 claims abstract description 7
- 241000206469 Pulsatilla Species 0.000 claims abstract description 7
- 244000111489 Gardenia augusta Species 0.000 claims abstract 3
- 241000628997 Flos Species 0.000 claims description 19
- 241001057584 Myrrha Species 0.000 claims description 12
- 210000000582 Semen Anatomy 0.000 claims description 12
- 230000002980 postoperative Effects 0.000 claims description 12
- 239000009286 sanguis draxonis Substances 0.000 claims description 12
- 235000016993 Agrimonia Nutrition 0.000 claims description 6
- 241000245240 Lonicera Species 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 6
- 241000405217 Viola <butterfly> Species 0.000 claims description 6
- 239000009806 pulsatillae Substances 0.000 claims description 6
- 241000208340 Araliaceae Species 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 14
- 229940079593 drugs Drugs 0.000 abstract description 6
- 231100000486 side effect Toxicity 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract 1
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 229940116229 Borneol Drugs 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 abstract 1
- 240000000805 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 240000004331 Plantago major Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 240000002195 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 240000006688 Telosma cordata Species 0.000 abstract 1
- 235000017352 Telosma cordata Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 229930006709 borneol Natural products 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 235000009242 dandelion Nutrition 0.000 abstract 1
- 235000014079 dandelion Nutrition 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 210000004369 Blood Anatomy 0.000 description 28
- 239000008280 blood Substances 0.000 description 28
- 208000002193 Pain Diseases 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 201000010099 diseases Diseases 0.000 description 12
- 208000001848 Dysentery Diseases 0.000 description 9
- 230000003628 erosive Effects 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 206010022114 Injuries Diseases 0.000 description 8
- 240000004678 Panax pseudoginseng Species 0.000 description 8
- 230000001717 pathogenic Effects 0.000 description 8
- 206010018987 Haemorrhages Diseases 0.000 description 7
- 231100000614 Poisons Toxicity 0.000 description 7
- 230000001737 promoting Effects 0.000 description 6
- 230000001047 pyretic Effects 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 201000000736 amenorrhea Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000000740 bleeding Effects 0.000 description 5
- 231100000319 bleeding Toxicity 0.000 description 5
- 239000000843 powders Substances 0.000 description 5
- 239000003440 toxic substances Substances 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 210000000988 Bone and Bones Anatomy 0.000 description 4
- 206010016286 Febrile diseases Diseases 0.000 description 4
- 241000157835 Gardenia Species 0.000 description 4
- 210000003205 Muscles Anatomy 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010072736 Rheumatic diseases Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 201000009910 diseases by infectious agent Diseases 0.000 description 4
- 230000002147 killing Effects 0.000 description 4
- 244000052769 pathogens Species 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 210000001015 Abdomen Anatomy 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 210000003734 Kidney Anatomy 0.000 description 3
- 241000321541 Leptolegnia sp. Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000000240 adjuvant Effects 0.000 description 3
- 239000002671 adjuvants Substances 0.000 description 3
- 230000000202 analgesic Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000002401 inhibitory effects Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000025627 positive regulation of urine volume Effects 0.000 description 3
- 239000002994 raw materials Substances 0.000 description 3
- 230000000552 rheumatic Effects 0.000 description 3
- 230000002522 swelling Effects 0.000 description 3
- 239000011901 water Substances 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010002156 Anal fistula Diseases 0.000 description 2
- 206010003549 Asthenia Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 210000000481 Breast Anatomy 0.000 description 2
- 206010008254 Cervical cyst Diseases 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000002173 Dizziness Diseases 0.000 description 2
- 208000005679 Eczema Diseases 0.000 description 2
- 208000001780 Epistaxis Diseases 0.000 description 2
- 210000000981 Epithelium Anatomy 0.000 description 2
- 206010018836 Haematochezia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 210000004185 Liver Anatomy 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000004396 Mastitis Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000008425 Protein Deficiency Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000005687 Scabies Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- 206010068760 Ulcers Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003213 activating Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 201000003505 cervical polyp Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 201000004624 dermatitis Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 231100001003 eczema Toxicity 0.000 description 2
- 230000003203 everyday Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000002439 hemostatic Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000004054 inflammatory processes Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000002574 poisons Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- 231100000397 ulcers Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000006673 Asthma Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 210000001124 Body Fluids Anatomy 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- KMOWWVASYKQGSI-UHFFFAOYSA-N C(CC1C=C1)N=C Chemical compound C(CC1C=C1)N=C KMOWWVASYKQGSI-UHFFFAOYSA-N 0.000 description 1
- 210000003679 Cervix Uteri Anatomy 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000008313 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 206010013990 Dysuria Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 210000003128 Head Anatomy 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 210000002216 Heart Anatomy 0.000 description 1
- 208000006454 Hepatitis Diseases 0.000 description 1
- 206010020039 Hiccups Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 210000003026 Hypopharynx Anatomy 0.000 description 1
- 206010049949 Intercostal neuralgia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 210000004698 Lymphocytes Anatomy 0.000 description 1
- 206010027327 Menstrual diseases Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 210000000214 Mouth Anatomy 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 229940023488 Pill Drugs 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 210000004915 Pus Anatomy 0.000 description 1
- 206010037844 Rash Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 210000004706 Scrotum Anatomy 0.000 description 1
- 206010040872 Skin infection Diseases 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229940076185 Staphylococcus aureus Drugs 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 210000001138 Tears Anatomy 0.000 description 1
- 201000008908 Tietze's syndrome Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 231100000765 Toxins Toxicity 0.000 description 1
- 210000003932 Urinary Bladder Anatomy 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 210000001215 Vagina Anatomy 0.000 description 1
- 239000002253 acids Substances 0.000 description 1
- 239000003470 adrenal cortex hormones Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000001139 anti-pruritic Effects 0.000 description 1
- 230000000840 anti-viral Effects 0.000 description 1
- 239000003908 antipruritic agents Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 201000003988 chronic cervicitis Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001276 controlling effects Effects 0.000 description 1
- 201000002574 conversion diseases Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 201000008286 diarrhea Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 201000000297 erysipelas Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000003419 expectorant Effects 0.000 description 1
- 239000003172 expectorant agents Substances 0.000 description 1
- 239000000796 flavoring agents Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effects Effects 0.000 description 1
- 239000004615 ingredients Substances 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 230000003211 malignant Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000002481 myositis Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000000414 obstructive Effects 0.000 description 1
- 230000000242 pagocytic Effects 0.000 description 1
- 244000045947 parasites Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pills Substances 0.000 description 1
- 239000011148 porous materials Substances 0.000 description 1
- 230000003389 potentiating Effects 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 230000000268 renotropic Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 239000003053 toxins Substances 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 210000004881 tumor cells Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 200000000019 wounds Diseases 0.000 description 1
Abstract
本发明公开了一种用于宫颈炎、宫颈肥大术后康复的中药制剂，由下列重量份配比的中药制备而成：当归2-8份，丹参1-5份，骨碎补1-5份，清半夏1-5份，白芨1-4份，白芷1-4份，生大黄2-8份，黄连1-5份，蒲公英1-6份，金银花1-6份，血竭1-3份，栀子1-5份，川芎1-3份，冰片1-5份，乳香0.5-1.2份，没药0.5-1.2份，木通0.3-0.6份，车前子1-3份，牡丹皮1-3份，萹蓄1-3份，蛇床子1-3份，虎杖3-10份，仙鹤草1-5份，白头翁1-3份，紫花地丁1-4份，败酱草1-5份，和人参1-3份。它是一种纯中药制剂，毒副作用小，药源广、成本低、疗效高、建议临床推广应用。
Description
一种用于宫颈炎、宫颈肥大术后康复的中药制剂
技术领域
[0001] 本发明涉及一种中药制剂，具体地说，涉及一种用于治疗宫颈炎宫颈肥大术后康复的中药制剂。
背景技术
[0002] 宫颈糜烂是慢性宫颈炎常见的临床表现，宫颈糜烂是妇女的常见病，约占妇科疾病的56%，是诱发宫颈癌高危因素，已经成了威胁女性心身健康的主要疾病之一，宫颈糜烂癌变的症状有很多，最常见是白带增多，白带常为水样或浆液状，随着宫颈癌肿瘤病程的进展可出现米汤样或版血相混杂的分泌物，臭味异常，有时俘有块状及坏死的肿瘤组织。
[0003] 如果不及时治疗，宫颈糜烂很有可能引起癌变。而对其治疗最有效的措施是物理治疗，包括电熨、激光、波姆光、冷冻、红外光等治疗，机制均是使炎症局部柱状上皮坏死脱落，新生鳞状上皮组织再生。但它存在局部水肿、大量长期排液、脱痂出血、愈合期长甚至感染等副作用，给病人带来痛苦是众所周知的。
[0004] 因此，女性患者平时要多关注自己的体征，以及要做好每年的妇科检查，如果有不放心的现象，还可以选择做一下TCT防癌筛查，确保自己的健康。
[0005] 宫颈疾病术后的康复治疗，医学杂志未见疗效突出的治疗报道。
发明内容
[0006] 本发明需要解决的技术问题就在于克服现有技术的缺陷，提供一种用于宫颈炎、 宫颈肥大术后康复的中药制剂，它是一种纯中药制剂，毒副作用小，药源广、成本低、疗效高、建议临床推广应用。
[0007] 为解决上述问题，本发明采用如下技术方案：
[0008] 本发明一种用于宫颈炎、宫颈肥大术后康复的中药制剂，所述中药制剂由下列重量份配比的中药制备而成：
[0009] 当归2-8份，丹参1-5份，骨碎补1-5份，清半夏1_5份，白芨1_4份，白芷1_4份， 生大黄2-8份，黄连1-5份，蒲公英1-6份，金银花1-6份，血竭1-3份，桅子1_5份，川芎 1-3份，冰片1-5份，乳香0. 5-1. 2份，没药0. 5-1. 2份，木通0. 3-0. 6份，车前子1_3份，牡丹皮1-3份，篇蓄1-3份，蛇床子1-3份，虎杖3-10份，仙鹤草1-5份，白头翁1_3份，紫花地丁 1-4份，败酱草1-5份，和人参1-3份。
[0010] 或者，所述中药制剂由下列重量份配比的中药制备而成：
[0011] 当归2份，丹参5份，骨碎补1份，清半夏5份，白芨1份，白芷4份，生大黄2份， 黄连5份，蒲公英1份，金银花6份，血竭1份，桅子5份，川弯1份，冰片5份，乳香0. 5份， 没药1. 2份，木通0. 3份，车前子3份，牡丹皮1份，篇蓄3份，蛇床子1份，虎杖10份，仙鹤草1份，白头翁3份，紫花地丁 1份，败酱草5份，和人参1份。
[0012] 或者，所述中药制剂由下列重量份配比的中药制备而成：
[0013] 当归8份，丹参1份，骨碎补5份，清半夏1份，白芨4份，白芷1份，生大黄8份，黄连1份，蒲公英6份，金银花1份，血竭3份，桅子1份，川弯3份，冰片1份，乳香1. 2份， 没药0. 5份，木通0. 6份，车前子1份，牡丹皮3份，篇蓄1份，蛇床子3份，虎杖3份，仙鹤草5份，白头翁1份，紫花地丁 4份，败酱草1份，和人参3份。
[0014] 或者，所述中药制剂由下列重量份配比的中药制备而成：
[0015] 当归5份，丹参3份，骨碎补3份，清半夏3份，白芨2份，白芷2份，生大黄5份，黄连3份，蒲公英4份，金银花4份，血竭1. 5份，桅子3份，川弯2份，冰片3份，乳香1份，没药1份，木通0. 5份，车前子1. 5份，牡丹皮1. 5份，篇蓄1. 5份，蛇床子1. 5份，虎杖6份， 仙鹤草3份，白头翁1. 5份，紫花地丁 2份，败酱草3份，和人参1. 5份。
[0016] 本发明中：
[0017] 当归，补血活血，润肠通便。用于血虚萎黄、眩晕心悸、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
[0018] 丹参，味苦、微辛，性微寒；心、脾、肝、肾血分之药；具有活血祛瘀，养血安神，凉血消肿的功效；主治瘀血头、胸、胁、腹疼痛，积聚，月经不调，痛经经闭，产后瘀滞腹痛，关节痹痛，跌打瘀肿，温病心烦，血虚心悸，疮疡肿毒，丹疹疥癣。
[0019] 骨碎补，补肾强骨，续伤止痛。用于肾虚腰痛，耳鸣耳聋，牙齿松动，跌扑闪挫，筋骨折伤。
[0020] 半夏，燥湿化痰；降逆止呕；消痞散结，用于痰多咳嗽，用于胸脘痞闷，胸痹，结胸等症，用于瘿瘤瘰历，疮疡肿痛，梅核气等症，.用于胃气上逆，恶心呕吐。
[0021] 白芨，具有较好的收敛止血，消肿生肌功效。随着现代药理学的研究不断深入，发现其对结核杆菌，肿瘤细胞等有明显抑制作用。临床发现，还对常见病有较好疗效。
[0022] 白芷，利血脉，祛风散寒，除湿通络，广泛用于软组织挫伤、骨质增生、肌肉劳损、风湿性肌炎、骨折、肋软骨炎、肩周炎、肋间神经痛等疾病的疼痛。
[0023] 生大黄，清热、凉血，躁湿，导滞，可治火热内盛。
[0024] 黄连，清热燥湿，泻火解毒。用于湿热痞满，呕吐吞酸，泻痢。
[0025] 蒲公英，清热解毒可用于热毒证，尤善清肝热，治疗肝热目赤肿痛，以及多种感染、 化脓性疾病。消痈散结治疗热毒壅结于肌肉所致的痈肿疮毒，高热不退。对乳痈有良效，能解毒散结通乳，可内服或外敷，常配金银花等同用。另外还可配大黄、牡丹皮治疗肠痈。
[0026] 金银花，又称为金银花，自古被誉为清热解毒的良药。它性甘寒气芳香，甘寒清热而不伤胃，芳香透达又可祛邪。金银花既能宣散风热，还善清解血毒，用于各种热性病，如身热、发疹、发斑、热毒疮痈、咽喉肿痛等证，均效果显著。药理研究表明，金银花中的有效成分主要有三方面作用：一是抗菌及抗病毒。即对金黄色葡萄球菌、溶血性链球菌、痢疾杆菌、 伤寒杆菌、脑膜炎双球菌、肺炎双球菌、绿脓杆菌以及流感病毒等都有明显抑制作用。二是有增强免疫的功能。金银花能促进淋巴细胞转化，增强白细胞的吞噬功能。三是抗炎、解热。 金银花能促进肾上腺皮质激素的释放，对炎症有明显抑制作用。
[0027] 血竭，散瘀定痛，止血生肌。治跌打折损，内伤瘀痛；外伤出血不止，瘰疬，臁疮溃久不合。
[0028] 桅子，清热凉血桅子花苦寒，能人血分而清邪热，是疮肿毒，肠风下痢，血热妄行等病症的辅助治疗食品。
[0029] 川芎，性温，是妇科常用药品，有活血顺气的作用。
4[0030] 冰片，开窍醒神，清热止痛。
[0031] 乳香，调气活血，定痛，追毒。治气血凝滞、心腹疼痛，痈疮肿毒，跌打损伤，痛经，产后瘀血刺痛。
[0032] 没药，散血去瘀，消肿定痛。主治治跌打损伤，金疮，筋骨，心腹诸痛，症瘕，经闭，痈疽肿痛，痔漏，目障。
[0033] 木通，能够泻火行水，通利血脉。治小便赤涩，淋池，水肿，胸中烦热，喉痹咽痛，遍身拘痛，妇女经闭，乳汁不通等。
[0034] 车前子，清热利尿；渗湿止泻；明目；祛痰。主小便不利；淋浊带下；水肿胀满；暑湿泻痢；目赤障翳；痰热咳喘。
[0035] 牡丹皮，清热；活血散瘀。主温热病热入血分；发斑；吐衄；热泪盈眶病菌后期热伏阴分发热；阴虚骨蒸潮热；血滞经闭；痛经；痈肿疮毒；跌扑伤痛；风湿热痹。
[0036] 篇蓄，主治利尿通淋，杀虫，止痒。用于膀胱热淋、小便短赤、淋浙涩痛、皮肤湿疹、 阴痒带下。
[0037] 蛇床子，温肾助阳，祛风，燥湿，杀虫。主治：男子阳痿，阴囊湿痒，女子带下阴痒，子宫寒冷不孕，风湿痹痛，疥癣湿疮。
[0038] 虎杖，祛风，利湿，破瘀，通经。治风湿筋骨疼痛，湿热黄疸，淋浊带下，妇女经闭， 产后恶露不下，癥瘕积聚，痔漏下血。跌扑损伤，烫伤，恶疮癣疾。
[0039] 仙鹤草，收敛止血，补虚，止痢，杀虫。主治於咯血，吐血，便血，崩漏，泻痢，脱力劳伤，疮疖痈肿，阴痒带下。
[0040] 白头翁，具有清热解毒，凉血止痢，燥湿杀虫的功效；主治热毒痢疾，鼻衄，血痔，带下，阴痒，痈疮，瘰疬
[0041] 紫花紫花地丁，清热解毒，兼以消肿散结。用于疔疮、乳痈、肠痈、丹毒，
[0042] 败酱草，清热解毒，祛瘀排脓。用于阑尾炎、痢疾、肠炎、肝炎、眼结膜炎、产后瘀血腹痛、痈肿疔疮。
[0043] 人参，大补元气，固脱生津，安神。治劳伤虚损，食少，倦怠，反胃吐食，大便滑泄，虚咳喘促，自汗暴脱，惊悸，健忘，眩晕头痛，阳痿，尿频，消渴，妇女崩漏，小儿慢惊，及久虚不复，一切气血津液不足之证。
[0044] 本发明用于宫颈糜烂、宫颈炎、宫颈肥大、宫颈息肉、宫颈囊肿等术后的康复治疗。 废除了传统以纱布压迫止血的常规治疗、每日外用药一次，4-5周恢复正常。
[0045] 本发明药源广、成本低、疗效高、建议临床推广应用。
具体实施方式
[0046] 实施例1
[0047] 当归5份，丹参3份，骨碎补3份，清半夏3份，白芨2份，白芷2份，生大黄5份，黄连3份，蒲公英4份，金银花4份，血竭1. 5份，桅子3份，川弯2份，冰片3份，乳香1份，没药1份，木通0. 5份，车前子1. 5份，牡丹皮1. 5份，篇蓄1. 5份，蛇床子1. 5份，虎杖6份， 仙鹤草3份，白头翁1. 5份，紫花地丁 2份，败酱草3份，和人参1. 5份。
[0048] 将中药原料按上述比例磨成粉剂，配合辅料制备成散剂，外用于治疗的病灶处。
[0049] 实施例2[0050] 当归2份，丹参5份，骨碎补1份，清半夏5份，白芨1份，白芷4份，生大黄2份， 黄连5份，蒲公英1份，金银花6份，血竭1份，桅子5份，川弯1份，冰片5份，乳香0. 5份， 没药1. 2份，木通0. 3份，车前子3份，牡丹皮1份，篇蓄3份，蛇床子1份，虎杖10份，仙鹤草1份，白头翁3份，紫花地丁 1份，败酱草5份，和人参1份。
[0051] 将中药原料按上述比例磨成粉剂，配合辅料制备成散剂，外用于治疗的病灶处。
[0052] 实施例3
[0053] 当归8份，丹参1份，骨碎补5份，清半夏1份，白芨4份，白芷1份，生大黄8份， 黄连1份，蒲公英6份，金银花1份，血竭3份，桅子1份，川弯3份，冰片1份，乳香1. 2份， 没药0. 5份，木通0. 6份，车前子1份，牡丹皮3份，篇蓄1份，蛇床子3份，虎杖3份，仙鹤草5份，白头翁1份，紫花地丁 4份，败酱草1份，和人参3份。
[0054] 将中药原料按上述比例磨成粉剂，配合辅料制备成蜜丸，外用于治疗的病灶处。
[0055] 实施例4
[0056] 将实施例1制备的中药制剂用于宫颈糜烂、宫颈炎、宫颈肥大、宫颈息肉、宫颈囊肿等术后的康复治疗。废除了传统以纱布压迫止血的常规治疗，外用于治疗的病灶处，每日外用药一次，4-5周恢复正常，术后阴道大量排液由逐渐增多到逐渐减少，病灶治疗处无出血，腰痛逐渐减轻，患者面部斑逗逐渐消失，面容毛孔缩小，皮肤光泽。经治560例、治愈550 例、显效10例。治疗标准为痊愈：宫颈糜烂消失，宫颈光滑；显效：宫颈糜烂面缩小；无效： 宫颈糜烂面未消失。
[0057] 最后应说明的是：显然，上述实施例仅仅是为清楚地说明本发明所作的举例，而并非对实施方式的限定。对于所属领域的普通技术人员来说，在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无需也无法对所有的实施方式予以穷举。而由此所引伸出的显而易见的变化或变动仍处于本发明的保护范围之中。
Claims (4)
1. 一种用于宫颈炎、宫颈肥大术后康复的中药制剂，其特征在于：所述中药制剂由下列重量份配比的中药制备而成：当归2-8份，丹参1-5份，骨碎补1-5份，清半夏1-5份，白芨1-4份，白芷1_4份，生大黄2-8份，黄连1-5份，蒲公英1-6份，金银花1-6份，血竭1-3份，桅子1_5份，川芎1_3 份，冰片1-5份，乳香0. 5-1. 2份，没药0. 5-1. 2份，木通0. 3-0. 6份，车前子1_3份，牡丹皮 1-3份，篇蓄1-3份，蛇床子1-3份，虎杖3-10份，仙鹤草1-5份，白头翁1_3份，紫花地丁 1-4份，败酱草1-5份，和人参1-3份。
2.如权利要求1所述的用于宫颈炎、宫颈肥大术后康复的中药制剂，其特征在于：所述中药制剂由下列重量份配比的中药制备而成：当归2份，丹参5份，骨碎补1份，清半夏5份，白芨1份，白芷4份，生大黄2份，黄连 5份，蒲公英1份，金银花6份，血竭1份，桅子5份，川弯1份，冰片5份，乳香0. 5份，没药 1. 2份，木通0. 3份，车前子3份，牡丹皮1份，篇蓄3份，蛇床子1份，虎杖10份，仙鹤草1 份，白头翁3份，紫花地丁 1份，败酱草5份，和人参1份。
3.如权利要求1所述的用于宫颈炎、宫颈肥大术后康复的中药制剂，其特征在于：所述中药制剂由下列重量份配比的中药制备而成：当归8份，丹参1份，骨碎补5份，清半夏1份，白芨4份，白芷1份，生大黄8份，黄连 1份，蒲公英6份，金银花1份，血竭3份，桅子1份，川弯3份，冰片1份，乳香1. 2份，没药 0. 5份，木通0. 6份，车前子1份，牡丹皮3份，篇蓄1份，蛇床子3份，虎杖3份，仙鹤草5 份，白头翁1份，紫花地丁 4份，败酱草1份，和人参3份。
4.如权利要求1所述的用于宫颈炎、宫颈肥大术后康复的中药制剂，其特征在于：所述中药制剂由下列重量份配比的中药制备而成：当归5份，丹参3份，骨碎补3份，清半夏3份，白发2份，白主2份，生大黄5份，黄连 3份，蒲公英4份，金银花4份，血竭1. 5份，桅子3份，川弯2份，冰片3份，乳香1份，没药 1份，木通0. 5份，车前子1. 5份，牡丹皮1. 5份，篇蓄1. 5份，蛇床子1. 5份，虎杖6份，仙鹤草3份，白头翁1. 5份，紫花地丁 2份，败酱草3份，和人参1. 5份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101440513A CN101791377B (zh) | 2010-04-12 | 2010-04-12 | 一种用于宫颈炎、宫颈肥大术后康复的中药制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101440513A CN101791377B (zh) | 2010-04-12 | 2010-04-12 | 一种用于宫颈炎、宫颈肥大术后康复的中药制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101791377A CN101791377A (zh) | 2010-08-04 |
| CN101791377B true CN101791377B (zh) | 2012-02-29 |
Family
ID=42584437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101440513A CN101791377B (zh) | 2010-04-12 | 2010-04-12 | 一种用于宫颈炎、宫颈肥大术后康复的中药制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101791377B (zh) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102225158B (zh) * | 2011-06-07 | 2012-08-29 | 李洁 | 一种治疗妇科急性宫颈炎的中药宫炎散 |
| CN102670982A (zh) * | 2012-01-15 | 2012-09-19 | 河南科技大学 | 一种用于治疗宫颈糜烂的中药组合物 |
| CN102727767B (zh) * | 2012-06-17 | 2013-10-16 | 赵青 | 一种治疗渗出型慢性子宫颈炎的中药冲洗剂制备方法 |
| CN102961552B (zh) * | 2012-12-24 | 2014-03-26 | 李宝 | 一种鼻腔创口恢复用药 |
| CN103251917B (zh) * | 2013-05-31 | 2015-06-03 | 赵彦强 | 一种治疗妇科疾病的中药栓剂 |
| CN103583734B (zh) * | 2013-10-22 | 2016-04-20 | 朱霞 | 一种南瓜蒂茶冲剂及其制备方法 |
| CN103830517A (zh) * | 2014-03-08 | 2014-06-04 | 张彦美 | 一种治疗宫颈炎的中药制剂及制备方法 |
| CN103860956A (zh) * | 2014-03-11 | 2014-06-18 | 张家能 | 一种治疗囊肿的中药组合物 |
| CN104771480A (zh) * | 2014-05-15 | 2015-07-15 | 刘善奎 | 一种治疗宫颈息肉中药栓剂的制备方法 |
| CN105477489A (zh) * | 2014-05-15 | 2016-04-13 | 刘善奎 | 治疗宫颈肥大的栓剂的制备方法 |
| CN104225337A (zh) * | 2014-10-08 | 2014-12-24 | 张文艳 | 治疗慢性宫颈炎的组合中药 |
| CN104983954A (zh) * | 2015-02-06 | 2015-10-21 | 李志刚 | 一种治疗宫颈肥大的药剂 |
| CN104740528B (zh) * | 2015-03-06 | 2018-06-26 | 河南中医学院 | 一种治疗宫颈炎的中药粉 |
| CN104825724A (zh) * | 2015-05-28 | 2015-08-12 | 青岛辰达生物科技有限公司 | 一种用于慢性宫颈炎术后康复的中药制剂 |
| CN106166197A (zh) * | 2016-08-17 | 2016-11-30 | 通化万通药业股份有限公司 | 消糜栓 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1977904A (zh) * | 2006-12-20 | 2007-06-13 | 北京润德康医药技术有限公司 | 一种用于盆腔炎、附件炎等妇科炎症的中药组合物 |
| CN101167870A (zh) * | 2007-11-13 | 2008-04-30 | 徐究竟 | 治疗宫颈糜烂的药物及其制备工艺 |
-
2010
- 2010-04-12 CN CN2010101440513A patent/CN101791377B/zh not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1977904A (zh) * | 2006-12-20 | 2007-06-13 | 北京润德康医药技术有限公司 | 一种用于盆腔炎、附件炎等妇科炎症的中药组合物 |
| CN101167870A (zh) * | 2007-11-13 | 2008-04-30 | 徐究竟 | 治疗宫颈糜烂的药物及其制备工艺 |
Non-Patent Citations (1)
| Title |
|---|
| 孟宪红.慢性宫颈炎的认识及中西医治疗.《中国乡村医药杂志》.2009,第16卷(第10期),8-9. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101791377A (zh) | 2010-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101564521B (zh) | 一种治疗乳腺增生的外用膏药 | |
| CN102151325B (zh) | 一种治疗乳腺疾病的中药 | |
| CN101229357B (zh) | 一种治疗乳腺增生的中药 | |
| CN101584773B (zh) | 一种治疗皮肤病的中草药 | |
| CN101879301B (zh) | 一种治疗慢性宫颈炎的中草药制剂 | |
| CN100417403C (zh) | 治疗癌症的中药 | |
| CN103550517B (zh) | 一种治疗肝癌的药物 | |
| CN102068641B (zh) | 一种治疗妇科疾病的中药胶囊 | |
| CN101721664A (zh) | 一种治疗中风偏瘫及全身瘫痪的中药 | |
| CN101934025B (zh) | 一种用于清热解毒的中药 | |
| CN102671129B (zh) | 一种治疗宫颈癌的中药组合物 | |
| CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
| CN103239659A (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
| CN103550695B (zh) | 一种治疗乳腺癌的药物 | |
| CN101791378B (zh) | 一种用于伤口止血、抗炎、生肌的中药制剂 | |
| CN101829217B (zh) | 治疗慢性结肠炎的中药 | |
| CN104474471A (zh) | 一种治疗甲状腺的中药组合物 | |
| CN101912468A (zh) | 治疗乳腺炎的中草药 | |
| CN103417790B (zh) | 治疗脑出血的中药 | |
| CN103877429B (zh) | 一种治疗鼻窦炎的中药制剂及制备方法 | |
| CN101239132B (zh) | 一种治疗骨折、跌打损伤的接骨药物 | |
| CN103816504A (zh) | 一种活血止痛膏及其制备方法 | |
| CN102526441B (zh) | 一种专治妇科炎症的中药冲洗液 | |
| CN104225138A (zh) | 一种通过内服外洗治疗褥疮的中药及其制备方法 | |
| CN104383390A (zh) | 一种治疗肺癌的中药制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| GR01 | Patent grant | ||
| C14 | Grant of patent or utility model | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120229 Termination date: 20170412 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |